Bracing For A Life Sciences Enforcement Zeitgeist: Part 2
By Gary Giampetruzzi and Sandra Gonzalez (November 3, 2017, 1:13 PM EDT) -- In the first part of this two-part article, we explored the risks attendant with German economic growth (noting that Germany is Europe's largest economy and the fourth largest economy in the world based on 2016 gross domestic product), as well as the investigative and enforcement mechanisms used by U.S. regulators to combat improper payments (i.e., bribes or kickbacks) in the U.S. ("over the past two decades, life sciences companies, in particular, have faced a virtual onslaught of U.S. government enforcement and have spent tens of billions of dollars in fines and penalties resulting from violations of various U.S. laws enacted to...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!